Examining the public provision and funding of clinical genetic tests

    Ano de publicação: 2017

    Since the completion of the Human Genome Project in the 1990s, there have been rapid advances of research in the area of genetics and genomics.(1) When combined with evolving medical technologies this has meant that the use of genetic testing and screening are increasingly common in the health system. Genetic tests can offer benefits for the diagnosis and treatment of conditions, identification of predisposition to a genetic disease, and even the tailoring of drugs and therapies to an individual’s genetic profile. In recent years however, there has been a large increase in the use of genetic tests, largely as a response to both the improved accuracy and availability of these tests, as well as to patient demands for enhanced personalized health information

    Mais relacionados